About Us

 

PathoFinder is a privately owned molecular diagnostics company founded in 2004. The company focuses on the development and commercialization of a new generation of molecular diagnostics, with special emphasis on infectious diseases. Our proprietary MultiFinder® and SmartFinder® technologies allows for the detection and differentiation of up to 22 viral and bacterial pathogens in a single assay. PathoFinder is based in Maastricht, The Netherlands.

PathoFinder is dedicated to the development, validation and production of high quality, sensitive and robust multiplex assays for the detection of multiple pathogens in a single assay.

The products are designed to work on many commercially available detection systems to enable a rapid introduction into molecular diagnostics laboratories.

PathoFinder will continue to develop new assays for several panel diseases like Respiratory Tract Infections (RTI's), Gastroenteritis, Human Papilloma Virus, Viral Meningitis and Sexually Transmitted Diseases (STD's).

Technology

SmartFinder®: Multiplex PCR Technology Based on Melt Curve Analysis
The SmartFinder® technology is PathoFinder’s proprietary state-of-the-art multiplex PCR technology for Real Time Molecular Diagnostics. It enables Single tube Multiplex Amplification in Real Time (SMART) of up to 22 infectious pathogens in a single clinical sample.

MultiFinder®: Multiplex PCR Technology Based on DNA Fragment Size Analysis
The MultiFinder® technology is PathoFinder's first generation of multiplex PCR technology. The MultiFinder® technology enables the detection and differentiation of up to 22 viral or bacterial targets in a single molecular diagnostic assay.

RealAccurate®: mono- and duplex RealTime PCR kits
PathoFinder also offers a number of Real Time PCR assays. These products contain optimized and validated sets of primers and probes for Real Time PCR. Using an uniform PCR protocol, RealAccurate® enables you to analyse multiple parameters at the same time in the same instrument. The RealAccurate® product line focuses the detection of respiratory viruses and bacteria, including mycobacterium tuberculosis.